Back
ESC Professional Premium Access

The effectiveness of ARNI medication in patients, non-responder to cardiac resynchronization therapy

Session: Heart failure pharmacotherapy - Sacubitril/valsartan
Topic: Pharmacotherapy
Speaker: Doctor K. Szabo (Debrecen, HU)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Krisztina Szabo

University of Debrecen, Debrecen (Hungary)
0 follower

7 more presentations in this session

Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan

Speaker: Assistant Professor A. Giannoni (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Maximum dose sacubitril/valsartan in heart failure with reduced ejection fraction: does atrial fibrillation compromise the benefits?

Speaker: Doctor G. Oliveira Campos (Coimbra, PT)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Bielecka-Dabrowa (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Effects of sacubitril valsartan on renal function in adults with heart failure: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Hernandez (Storrs, US)

Access
Abstract
Slides
Like
Thumbnail

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)

Speaker: Assistant Professor K. Lee (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart failure pharmacotherapy - Sacubitril/valsartan

Speakers: Doctor K. Szabo, Assistant Professor A. Giannoni, Doctor G. Oliveira Campos, Professor A. Bielecka-Dabrowa, Professor A. Hernandez...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources